FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

Published:2006-12 Issue:12 Volume:6 Page:2912-2921
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Salvadori M.,Budde K.,Charpentier B.,Klempnauer J.,Nashan B.,Pallardo L. M.,Eris J.,Schena F. P.,Eisenberger U.,Rostaing L.,Hmissi A.,Aradhye S.,

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2006.01552.x/fullpdf

Reference17 articles.

1. Immunosuppressive Drugs for Kidney Transplantation

2. FTY720 immunomodulation: optimism for improved transplant regimens

3. First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients

4. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study

5. FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of G protein coupled receptors in acute kidney injury;Cell Communication and Signaling;2024-09-02

2. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

3. Recent Insight into the Role of Sphingosine-1-Phosphate Lyase in Neurodegeneration;International Journal of Molecular Sciences;2023-03-24

4. Effect of fingolimod therapy on quantitative macular changes among patients with relapsing-remitting multiple sclerosis: a four-year follow-up study from Oman;BMC Ophthalmology;2022-12-05

5. New immunosuppressive agents in transplantation;La Presse Médicale;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3